Literature DB >> 15922982

Pregnancy and delivery after laparoscopic myomectomy.

Jun Kumakiri1, Hiroyuki Takeuchi, Mari Kitade, Iwaho Kikuchi, Hiroto Shimanuki, Shigeru Itoh, Katsuyuki Kinoshita.   

Abstract

STUDY
OBJECTIVE: To assess the factors influencing pregnancy outcome and evaluate vaginal birth after laparoscopic myomectomy (VBALM).
DESIGN: Retrospective study (Canadian Task Force classification II-2).
SETTING: University hospital. PATIENTS: One hundred eight patients who wanted a child after laparoscopic myomectomy (LM) and a follow-up of at least 6 months. INTERVENTION: Laparoscopic myomectomy.
MEASUREMENTS AND MAIN RESULTS: Forty-seven pregnancies occurred in 40 patients. As for the factors considered to contribute to pregnancy after LM, COX regression analysis showed that pregnancy after LM correlated positively with the diameter of the largest myoma (OR 1.06, 95% CI 1.02-1.10, p = .004) and negatively with the age of the patient at the time of LM (OR 0.88, 95% CI 0.80-0.98, p = .02) and the number of enucleated myomas (OR l.17, 95% CI 1.01-1.37, p=0.04). Vaginal birth after LM was managed in accordance with the standard management of vaginal birth after cesarean section (VBAC) in our hospital. Delivery after LM was accomplished in 32 pregnancies. Vaginal birth after laparoscopic myomectomy was attempted in 23 pregnancies (71.9%) and vaginal birth successful in 19 (82.6%) of these 23 pregnancies. Vaginal birth after LM was unsuccessful in four patients, as labor did not occur during more than 2 weeks after the expected date of delivery in two patients, and cesarean section was performed to prevent fetal asphyxia during the course of delivery in two patients. In the 18 patients (19 pregnancies) with successful VBALM, the diameter of the largest myoma at LM was 68.7 +/- 18.4 mm, the number of enucleated myomas was 2.9 +/- 2.1, and the number of hysterotomies was 2.5 +/- 1.8. As for the depth of the largest myoma, this was intramural in 12 patients, submucosal in 2 patients and subserosal in 4 patients. None of the patients, regardless of whether they had a successful VBALM or not, suffered uterine rupture during or after delivery.
CONCLUSION: Since nearly complete suturing is possible in LM as in laparotomy, vaginal delivery can be accomplished safely without uterine rupture even after LM, provided that delivery is managed as in VBAC.

Entities:  

Mesh:

Year:  2005        PMID: 15922982     DOI: 10.1016/j.jmig.2005.03.011

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  7 in total

1.  Laparoscopic management of large myomas.

Authors:  Rakesh Sinha; Meenakshi Sundaram
Journal:  J Gynecol Endosc Surg       Date:  2009-07

2.  Fibroids, infertility and laparoscopic myomectomy.

Authors:  Pankaj Desai; Purvi Patel
Journal:  J Gynecol Endosc Surg       Date:  2011-01

3.  Fertility and Symptom Relief following Robot-Assisted Laparoscopic Myomectomy.

Authors:  Michael C Pitter; Serene S Srouji; Antonio R Gargiulo; Leslie Kardos; Usha Seshadri-Kreaden; Helen B Hubert; Glenn A Weitzman
Journal:  Obstet Gynecol Int       Date:  2015-04-19

4.  Uterine rupture in pregnancy after robotic myomectomy.

Authors:  İsmet Hortu; Ali Akdemir; Fatih Şendağ; Mehmet Kemal Öztekin
Journal:  Turk J Obstet Gynecol       Date:  2015-09-15

5.  Impact of history of myomectomy on preterm birth risk in women with a leiomyomatous uterus: a propensity score analysis.

Authors:  Emmanuel Rault; Pierre Delorme; François Goffinet; Aude Girault
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-23       Impact factor: 3.007

6.  Learning curve of minimally invasive two-port laparoscopic myomectomy.

Authors:  Iwaho Kikuchi; Jun Kumakiri; Shozo Matsuoka; Satoru Takeda
Journal:  JSLS       Date:  2012 Jan-Mar       Impact factor: 2.172

7.  Feasibility and Safety of Absorbable Knotless Wound Closure Device in Laparoscopic Myomectomy.

Authors:  Chying-Chyuan Chan; Ching-Yu Lee
Journal:  Biomed Res Int       Date:  2016-06-27       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.